Northwest Biotherapeutics Inc logo

Northwest Biotherapeutics Inc

$ 0.68 +0.00334 (+0.49%) 03:57 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 706.46M
Enterprise V:
$ 729.51M
Volume:
1.48M
Avg Vol (2M):
1.53M
Also Trade In:
Volume:
1.48M
Market Cap $:
706.46M
PE Ratio:
At Loss
Avg Vol (2-Month):
1.53M
Enterprise Value $:
729.51M
PB Ratio:
0
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Northwest Biotherapeutics Inc is a biotechnology company involved in the development of cancer vaccines. The target is a broad range of solid-tumor cancers. The company has a proprietary manufacturing technology, which it uses to produce a personalized vaccine. The product portfolio includes product candidates such as DCVax-L, for patients with brain cancer; DCVax-Direct, direct injection into all types of inoperable solid tumor cancers, and DCVax for late-stage ovarian cancer. DCVax-Prostate, for late-stage prostate cancer, has received clearance from the U.S. Food and Drug Administration.
Name Current Vs Industry Vs History
Cash-To-Debt 0.15
Equity-to-Asset -3.33
Debt-to-Equity -0.34
Debt-to-EBITDA 0.22
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -46.16
Distress
Grey
Safe
Beneish M-Score -4.81
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 15.36
9-Day RSI 28.82
14-Day RSI 37.8
6-1 Month Momentum % -5.33
12-1 Month Momentum % -38.79

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.07
Quick Ratio 0.07
Cash Ratio 0.05

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -21.9

Financials

NWBO's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:NWBO

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1.23
EPS (TTM) ($) -0.07
Beta -0.4
Volatility % 83.37
14-Day RSI 37.8
14-Day ATR ($) 0.03414
20-Day SMA ($) 0.726571
12-1 Month Momentum % -38.79
52-Week Range ($) 0.3862 - 2.05
Shares Outstanding (Mil) 1,037.23

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Northwest Biotherapeutics Inc Filings

Document Form Filing Date
No Filing Data

Northwest Biotherapeutics Inc Analysis

Share your research

Headlines

See More
No news.